Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Iluminos Therapeutics LLC
Profile last edited on: 3/15/2023      CAGE: 83T77      UEI: QZG3UBAV73G9

Business Identifier: Novel small molecules for reatment of Alzheimer’s disease and other neurodegenerative/cognitive diseases
Year Founded
2018
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

12063 N Red Mountain Drive
Tucson, AZ 85755
   (480) 650-4423
   N/A
   N/A
Location: Single
Congr. District: 06
County: Pima

Public Profile

Iluminos Therapeutics LLC - a University of Arizona faculty (and student) start-up - licensed from the University patented compounds they had developed to treat neurodegenerative diseases like Alzheimer’s. The intent is to expand upon significant pre-clinical findings to push the series of compounds to clinical trials with Alzheimer’s disease patients. The compounds were designed and synthesized at the UA College of Pharmacy in collaboration with the Translational Genomics Research Institute.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$498,634
Phase II Dollars
$0
Total Awarded
$498,634

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $498,634
Project Title: Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome

Key People / Management

  Travis Dunckley -- Co-Founders

  Chris Hulme

  Yeng Jeng Shaw

Company News

There are no news available.